Article Clinical Trials Microdosing Topical 
Cannabis Law Report
NOVEMBER 24, 2019
The article argues for the implementation of nuanced risk assessment strategies for handling psychedelics in medicine, and predicts an expansion of psychedelic substances into mainstream medicine. Dr. Johnson recently spoke about microdosing and its affects on creativity. Participate in Our Studies. ANOREXIA NERVOSA. Upcoming Events.
Canna Law Blog
NOVEMBER 27, 2021
In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. Compass Pathways Releases Phase 2B Trial Results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 10, 2019
Read full article: [link]. ” Here’s some of the topics covered in their latest newsletter. Read the article to learn more about how providing support during a psilocybin session and integrating the experience afterwards are conducive for therapeutic benefits. Here’s the site [link]. Psychedelic Research News.
CannaMD
OCTOBER 7, 2019
The biological behaviors and results described in this article are presently thought to be a specific consequence of THC consumption. As counterintuitive as it might sound, this conclusion is actually in line with a growing number of studies. As of right now, THC is considered the chief cannabinoid that directly binds with CB1 receptors.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. David Rabin.
Expert insights. Personalized for you.
59 
Let's personalize your content